In yesterday’s Wall Street session, Sarepta Therapeutics Inc (NASDAQ:SRPT) shares traded at $79.97, up 8.74% from the previous session.
SRPT stock price is now -27.16% away from the 50-day moving average and -36.25% away from the 200-day moving average. The market capitalization of the company currently stands at $7.76B.
With the price target of $136, Deutsche Bank recently initiated with Hold rating for Sarepta Therapeutics Inc (NASDAQ: SRPT). On November 27, 2024, Needham reiterated its ‘Buy’ rating on the stock by increasing its target price from $205 to quote $202, while ‘H.C. Wainwright’ rates the stock as ‘Sell’
In other news, Nicaise Claude, Director sold 2,491 shares of the company’s stock on Mar 12 ’25. The stock was sold for $248,203 at an average price of $99.64. Upon completion of the transaction, the Director now directly owns 27,812 shares in the company, valued at $2.22 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 12 ’25, Director Nicaise Claude bought 2,491 shares of the business’s stock. A total of $248,226 was incurred on buying the stock at an average price of $99.65. A total of 6.07% of the company’s stock is owned by insiders.
During the past 12 months, Sarepta Therapeutics Inc has had a low of $73.06 and a high of $173.25. As of last week, the company has a debt-to-equity ratio of 0.88, a current ratio of 4.20, and a quick ratio of 3.18. According to the stock market information, the enterprise value for the company is $7747732992, which is based on a 33.55 price-to-earnings ratio, a 0.36 price-to-earnings-growth ratio, and a beta of 0.88. The fifty day moving average price for SRPT is $109.7868 and a two-hundred day moving average price translates $125.4508 for the stock.
The latest earnings results from Sarepta Therapeutics Inc (NASDAQ: SRPT) was released for 2024-12-31. The net profit margin was 12.37% and return on equity was 19.71% for SRPT. The company reported revenue of $658.41 million for the quarter, compared to $396.78 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 65.94 percent.
